Study
Tannin-Based Supplement Eases IBS Symptoms in Adults Under 70
A tannin-based supplement showed improvement in IBS symptoms and quality of life for individuals under 70.
Summary
In plain language
Research has found that a supplement containing tannin phytocomplexes can help alleviate symptoms of irritable bowel syndrome (IBS) in adults under 70. Participants taking the supplement reported reduced gastrointestinal discomfort and an improved quality of life compared to those taking a placebo. This study is significant because IBS, a common digestive disorder, often leads to abdominal pain and changes in bowel habits, impacting daily living. The findings suggest that tannin-based supplements could be a beneficial option for managing IBS symptoms, providing a potential alternative for individuals seeking relief from this condition. Seniors experiencing IBS symptoms might consider discussing this option with their healthcare provider.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study involved 156 adults diagnosed with IBS, who were divided into two groups: one taking a tannin-based supplement and the other a placebo. The study lasted 56 days, with participants self-reporting their symptoms and quality of life.
Participants taking the supplement experienced significant improvement in IBS symptoms and quality of life compared to the placebo group.
The study was a double-blind, placebo-controlled trial, ensuring the reliability of the results.
Possible limitations include the age restriction and the focus on moderate IBS symptoms, which may not apply to all seniors.
If you're experiencing IBS symptoms, discussing this supplement with your healthcare provider could be worthwhile.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Tannin-Based Supplement Eases IBS Symptoms in Adults Under 70
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 26, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly due to its rigorous design, including randomization, blinding, and comprehensive statistical methods. Transparency was ensured through pre-registration and adherence to CONSORT guidelines. However, the lack of replication evidence and specific relevance to the target population of seniors aged 55+ limited the scores in those categories. Journal quality could not be assessed due to unspecified publication details.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study evaluates the efficacy of a tannin-based supplement in improving IBS symptoms in adults aged 18-70. It was a randomized, double-blind, placebo-controlled trial showing significant symptom improvement in the treatment group over 56 days.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.